Elsevier Inc.

SHERPA: Unknown

People

  1. Hanash
    Hanash
  2. Van Den Brink
    Van Den Brink
  3. Ponce
    Ponce
  4. Perales
    Perales
  5. Devlin
    Devlin
  6. Giralt
    Giralt
  7. Tsai
    Tsai
  8. Young
    Young
  9. Peled
    Peled
  10. Scaradavou
    Scaradavou

Groups

  1. Bone Marrow Transplant (23)
  2. Center for Hematologic Malignancies (23)
  3. Department of Medicine (23)
  4. Executive Committee, Center for Hematologic Malignancies (23)
  5. GSK Faculty (23)
  6. Hematologic Malignancies, Division of (23)
  7. Human Oncology and Pathogenesis Program (23)
  8. Immunology Program Faculty (23)
  9. Sloan Kettering Institute Faculty (23)
  10. Sloan Kettering Institute Postdocs (12)
Search Within
  1. "Marcel Van Den Brink"
  2. "Alan Hanash"
  3. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (4)
  3. Book Section (1)
Groups
  1. Bone Marrow Transplant (23)
  2. Center for Hematologic Malignancies (23)
  3. Department of Medicine (23)
  4. Executive Committee, Center for Hematologic Malignancies (23)
  5. GSK Faculty (23)
  6. Hematologic Malignancies, Division of (23)

More Groups

People
  1. Alan Hanash (23)
  2. Marcel Van Den Brink (23)
  3. Robert Jenq (12)
  4. Odette Smith (9)
  5. Doris Ponce (8)
  6. Juliet Barker (8)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2018 (3)
  4. 2016 (2)
  5. 2015 (4)
  6. 2014 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (22)
  2. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (1)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract
    Meeting Abstract

    Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Sandhu, K. S.; Barker, J. N.; Shia, J.; Yan, X; Daley, W. L.; Moore, G.; Fatmi, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Graft-versus-host disease leads to systemic elimination of innate lymphoid cells and abolishes their development
    Meeting Abstract

    Vinci, P.; Garcia-Martinez, E.; O'Connor, M. H.; Egorova, A.; Mertelsmann, A. M.; Nicoletti, E.; Geary, C. D.; Devlin, S. M.; van den Brink, M. R. M.; Jenq, R. R.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • An analysis of the correlation between gastro-intestinal (GI) symptoms, macroscopic appearance, histology & acute GVHD (aGVHD) treatment responses in cord blood transplant (CBT) recipients: Significant implications for aGVHD management
    Meeting Abstract

    Castillo Flores, N.; Politikos, I.; Maloy, M. A.; Naputo, K.; Hanash, A. M.; Peled, J. U.; van den Brink, M. R. M.; Ponce, D. M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Nrf2 is a critical mediator of CD4 T cell-induced acute graft-versus-host disease
    Meeting Abstract

    Tsai, J. J.; Velardi, E.; Shono, Y.; Argyropoulos, K.; Smith, O. M.; Lazrak, A.; Liu, C.; Murphy, G. F.; Fu, Y. Y.; Hanash, A. M.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries
    Meeting Abstract

    Velardi, E.; Tsai, J. J.; Radtke, S.; Cooper, K.; Argyropoulos, K.; Jae-Hung, S.; Jenq, R. R.; Hanash, A. M.; Moore, M.; Kiem, H. P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Interleukin-22 treatment promotes intestinal stem cell mediated epithelial regeneration via Stat3 activation and reduces GI GVHD
    Meeting Abstract

    Lindemans, C. A.; Calafiore, M.; O'Connor, M.; Mertelsmann, A.; van den Brink, M. R. M.; Hanash, A. M.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Intestinal Blautia is associated with reduced death from graft-versus-host disease
    Journal Article

    Jenq, R. R.; Taur, Y.; Devlin, S. M.; Ponce, D. M.; Goldberg, J. D.; Ahr, K. F.; Littmann, E. R.; Ling, L.; Gobourne, A. C.; Miller, L. C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save